{
    "nctId": "NCT06354478",
    "briefTitle": "IV Dexmedetomidine vs Oral Gabapentin and Their Combination for Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy",
    "officialTitle": "A Randomized, Double-blind Study to Compare the Efficacy of Intravenous Dexmedetomidine Infusion, Oral Gabapentin and Their Combination on Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Pain, Postoperative, Pain, Acute",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "The time to first rescue analgesia during the first 24 hour Postoperatively.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u25cf Female physical status ASA I, II.\n\n  * Body mass index (BMI): 20 kg/m2- 40 kg/m2.\n  * A patient undergoing modified radical mastectomy under general anaesthesia.\n\nExclusion Criteria:\n\n* \u25cf Patient refusal.\n\n  * Known sensitivity or contraindication to study drugs (e.g.: dexmedetomidine, gabapentin, or morphine ).\n  * History of psychological disorders, chronic pain, and/or sympathetic disorders.\n  * Patients receiving medications that are considered to result in tolerance to opioids as those who are receiving medications for cancer pain (e.g. tramadol and hydromorphone).\n  * Significant liver insufficiency (liver enzymes more than two folds or severe liver cirrhosis) or renal insufficiency (plasma creatinine more than 1.5 mg/dl).\n  * Severe respiratory disorders (e.g. Chronic obstructive pulmonary disease, Bronchial asthma), or cardiac disorders (e.g. ischemic heart disease, regional motion wall abnormality, EF\\< 50%).\n  * Pregnancy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}